rutin has been researched along with Pulmonary-Edema* in 2 studies
2 other study(ies) available for rutin and Pulmonary-Edema
Article | Year |
---|---|
Combining an in silico approach with an animal experiment to investigate the protective effect of troxerutin for treating acute lung injury.
Troxerutin (TRX), a naturally occurring flavonoid in various fruits, has been reported to exhibit numerous pharmacological and biological activities in vitro and in vivo. However, the molecular mechanisms underlying TRX as a treatment for disease are poorly understood.. Using pharmacophore mapping and inverse docking, a set of potential TRX target proteins that have been associated with multiple forms of diseases was obtained. Bioinformatic analyses were performed using the Enrichr and STRING servers to analyse the related biological processes and protein-protein networks. Furthermore, we investigated the potential protective effect of TRX against lipopolysaccharide-induced acute lung injury (ALI) using a mouse model. Morphological changes in the lungs were assessed using haematoxylin and eosin staining. Inflammatory cytokines, tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and IL-10 were investigated using ELISA. Activation of MAPK and NF-κB was detected using western blotting.. Our network pharmacology analysis revealed the existence of multiple TRX-related chemical-target interactions and the related biological processes. We found that pretreatment with TRX protected against histological changes and obviously regulated the inflammatory cell counts and inflammatory cytokine levels in bronchoalveolar lavage fluid. Based on bioinformatic and western blot analyses, TRX may exert a protective effect against ALI by inhibiting MAPK and NF-κB signalling.. TRX can ameliorate pulmonary injury by inhibiting the MAPK and NF-κB signalling pathways and has a potential protective effect against ALI. This study may be helpful for understanding the mechanisms underlying TRX action and for discovering new drugs from plants for the treatment of ALI. Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Computer Simulation; Cytokines; Drug Evaluation, Preclinical; Gene Ontology; Hydroxyethylrutoside; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Molecular Targeted Therapy; NF-kappa B; Phytotherapy; Plant Extracts; Pulmonary Edema | 2019 |
The fine structure of pulmonary contusion and the effect of various drugs.
The results of contusion were examined by electron and light microscopy in the lungs of rats. It was found that the results here were very similar to those elsewhere in the body, with a few minor modifications due to the unique structure of the lung. Densitometry of protein concentration and visual estimation of oedema were used to quantitate the effects on the injury. The benzo-pyrone drug Venalot had a considerable effect in reducing the protein concentration in the air spaces and the interstitial tissue, and of the oedema in the latter. Neither the proteinase inhibitor Trasylol nor the pectin-based plasma expander HAS had any significant effect on the fine structural alterations of pulmonary contusion. Topics: Animals; Aprotinin; Contusions; Coumarins; Drug Combinations; Hydroxyethylrutoside; Lung; Lung Injury; Male; Microscopy, Electron; Pectins; Plasma Substitutes; Proteins; Pulmonary Edema; Rats; Time Factors | 1976 |